BoneTape is an investigational, resorbable implant cut to shape for selected facial-fracture fixation without conventional drilling and screws. A registered 30-participant single-arm feasibility study addresses midface fractures, while NAMRU San Antonio reports a May 2026 ultrasonic-applicator demonstration and surgeon usability pilot. Earlier rabbit research supports preclinical alignment and healing observations. These are distinct stages of device development; human clinical results and regulatory clearance are not established by the inspected records.
Technical detail
Core features
Single-piece, cut-to-shape resorbable fixation
Ultrasonic applicator prototype demonstrated with artificial skulls in May 2026
Surgeon usability pilot supporting a planned FDA submission
Registered unblinded midface feasibility study with estimated enrolment of 30
NATO DIANA Mission Track follow-on acceleration pathway
Resorbable fixation
Medical device
Fracture repair
Trauma care
Investigational testing
Use & integration
Recorded applications
Craniofacial fracture repair
Orthopedic fixation research
Expeditionary medical care research
Trauma care
These describe the reviewed application scope, not confirmed deployments, released requirements or procurement eligibility.
Evidence of maturity
Investigational. NCT06600854 last posted an update in August 2025, lists recruiting and has no results; this is not fresh confirmation of current recruitment. Navy usability work and NATO DIANA progression support evaluation, not routine clinical procurement.
Commercial availability
Contact Cohesys about research collaboration and authorized study access. Confirm current recruitment, eligible indications and regulatory status; the cited sources do not establish routine commercial clinical use.
Integration and verification
Readiness
A technology readiness level is not established by the reviewed public sources.
A compact investigational fixation system may be relevant to distributed trauma-care logistics, but this is a derived relevance assessment and does not establish medical approval or military adoption.
This is a reviewed public-source assessment. It is not procurement eligibility, endorsement, customer interest, or classified demand.
Original sources 5 linked records
These records support this capability and its published Mission area and Defence need connections. A source count is not a count of independent confirmations.
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · defence applications
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technology readiness level
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · defence applications
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technical tags
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technical tags
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · capability type
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · summary
Cohesys' BoneTape is an investigational, single-piece resorbable fixation approach designed to be cut to shape and used without the conventional drilling and screw hardware associated with plate-based fracture repair.
Supports: Capability · name
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · commercial availability
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technicaldomainslugs
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technical tags
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · core features
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · summary
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technical tags
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · defence applications
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · technical tags
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Capability · defence applications
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Mission area · Edge Data Processing
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Mission area · Edge Data Processing
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Mission area · Edge Data Processing
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
Supports: Mission area · Edge Data Processing
A compact investigational fixation system may be relevant to distributed trauma-care logistics, but this is a derived relevance assessment and does not establish medical approval or military adoption.
Supports: Mission area · Edge Data Processing
Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.
ClinicalTrials.gov NCT06600854 is a sponsor-submitted, unblinded single-arm midface fracture feasibility study with 30 estimated participants, actual start May 5, 2025 and estimated completion May 1, 2027. The August 22, 2025 update lists recruiting and contains no results; this is not fresh confirmation of present enrolment.
Supports: Capability · commercial availability
ClinicalTrials.gov NCT06600854 is a sponsor-submitted, unblinded single-arm midface fracture feasibility study with 30 estimated participants, actual start May 5, 2025 and estimated completion May 1, 2027. The August 22, 2025 update lists recruiting and contains no results; this is not fresh confirmation of present enrolment.
The 2024 BoneTape paper reports a rabbit zygomatic-fracture model assessed over 2, 6 and 12 weeks. Alignment was better maintained with BoneTape and both groups united by 12 weeks. All named authors disclosed salary and/or equity interests in Cohesys, and animal findings do not establish human clinical outcomes.
NAMRU San Antonio reports a May 14–15, 2026 demonstration of a new BoneTape ultrasonic applicator on artificial skulls and a separate surgeon usability pilot intended to support a future FDA submission. This is not evidence of clearance or completed clinical efficacy testing.
Supports: Capability · core features
NAMRU San Antonio reports a May 14–15, 2026 demonstration of a new BoneTape ultrasonic applicator on artificial skulls and a separate surgeon usability pilot intended to support a future FDA submission. This is not evidence of clearance or completed clinical efficacy testing.
NATO DIANA’s original Mission Track announcement names Cohesys among fifteen 2026 innovators entering its follow-on acceleration pathway. The programme offers up to EUR300,000 additional contractual funding, but no Cohesys-specific award amount or operational medical adoption is established.
Supports: Capability · core features
NATO DIANA’s original Mission Track announcement names Cohesys among fifteen 2026 innovators entering its follow-on acceleration pathway. The programme offers up to EUR300,000 additional contractual funding, but no Cohesys-specific award amount or operational medical adoption is established.
Public sources cited · Facts and assessments kept separate · Human review
ClinicalTrials.gov NCT06600854 is a sponsor-submitted, unblinded single-arm midface fracture feasibility study with 30 estimated participants, actual start May 5, 2025 and estimated completion May 1, 2027. The August 22, 2025 update lists recruiting and contains no results; this is not fresh confirmation of present enrolment.
Supports: Capability · summary
ClinicalTrials.gov NCT06600854 is a sponsor-submitted, unblinded single-arm midface fracture feasibility study with 30 estimated participants, actual start May 5, 2025 and estimated completion May 1, 2027. The August 22, 2025 update lists recruiting and contains no results; this is not fresh confirmation of present enrolment.
Supports: Capability · core features
NAMRU San Antonio reports a May 14–15, 2026 demonstration of a new BoneTape ultrasonic applicator on artificial skulls and a separate surgeon usability pilot intended to support a future FDA submission. This is not evidence of clearance or completed clinical efficacy testing.
Supports: Capability · summary
NAMRU San Antonio reports a May 14–15, 2026 demonstration of a new BoneTape ultrasonic applicator on artificial skulls and a separate surgeon usability pilot intended to support a future FDA submission. This is not evidence of clearance or completed clinical efficacy testing.
Supports: Capability · commercial availability
NAMRU San Antonio reports a May 14–15, 2026 demonstration of a new BoneTape ultrasonic applicator on artificial skulls and a separate surgeon usability pilot intended to support a future FDA submission. This is not evidence of clearance or completed clinical efficacy testing.
